{"id":57826,"date":"2025-11-04T23:46:44","date_gmt":"2025-11-04T23:46:44","guid":{"rendered":"https:\/\/www.oxfordcorp.com\/?p=57826"},"modified":"2025-11-05T22:34:16","modified_gmt":"2025-11-05T22:34:16","slug":"50-capa-remediated-for-genomic-testing-manufacturer","status":"publish","type":"post","link":"https:\/\/www.oxfordcorp.com\/nl\/insights\/case-study\/50-capa-remediated-for-genomic-testing-manufacturer\/","title":{"rendered":"50 CAPA Remediated for Genomic Testing Manufacturer\u200b"},"content":{"rendered":"<div class=\"post-info\">\n<p><strong>INDUSTRY<\/strong><\/p>\n<p>Life Sciences<\/p>\n<p><strong>SERVICES<\/strong><\/p>\n<p>Gap Assessment<br \/>\nRoot Cause Analysis<br \/>\nCAPA Remediation<br \/>\nProcess Improvement<br \/>\nProject Management<\/p>\n<p><strong>SKILLS<\/strong><\/p>\n<p>CAPA Management<br \/>\nTechnical Writing<br \/>\nQuality Systems Remediation<br \/>\nProject Management<\/p>\n<\/div>\n<p><b>SITUATION<\/b><\/p>\n<p>Our client, a leading manufacturer of genomic profiling tests, received audit observations with FDA 21 CFR Part 820 and ISO 13485 as related to CAPA (Corrective and Preventive Action) management. Being relatively new to the regulatory industry and experiencing rapid growth at the same time, internal expertise in Quality and CAPA Management was lacking and related processes were at an early stage of maturity. Client was under increasing pressure from several key pharma partners to improve their quality processes, and had a significant CAPA backlog of various types, including but not limited to Technology, Product Development and Lab Operations. Many of these had been open for over 500 days. With a follow-up FDA audit anticipated, they needed urgent help to reduce the backlog and implement process improvements.\u200b<\/p>\n<p><b>SOLUTION<\/b><\/p>\n<p data-ccp-props=\"{&quot;335551550&quot;:1,&quot;335551620&quot;:1,&quot;335559683&quot;:0,&quot;335559685&quot;:0,&quot;335559731&quot;:0,&quot;335559737&quot;:0,&quot;335562764&quot;:2,&quot;335562765&quot;:1,&quot;335562766&quot;:4,&quot;335562767&quot;:0,&quot;335562768&quot;:4,&quot;335562769&quot;:0}\">Our team was engaged to provide Quality and CAPA Management and process expertise. We completed an assessment to catalog gaps with applicable regulations and standards, provided a remediation roadmap and then engaged a CAPA remediation team to complete the effort. Our team consisted of eight (8) experienced resources including an Engagement Manager, Project Manager, CAPA SME and CAPA Specialists that performed the remediation in eight (8) months. A structured communication plan was implemented to maintain transparency and focus on key issues and risks, including daily standup meetings, weekly leadership meetings, weekly status reports and dashboards, financial utilization reports and monthly engagement review meetings.<\/p>\n<p><b>RESULT<\/b><\/p>\n<p>Our team successfully improved the client\u2019s quality process, remediating 50 CAPA. A subsequent Premarket Approval (PMA) inspection conducted by the FDA, resulted in zero 483 observations. The FDA also reviewed the CAPA system that was part of the earlier 483 Observation review. The CAPA system was found to be compliant. This enabled the client to move its new technology to final PMA approval, which would then be made available to cancer patients on a global basis. The client extended our contract to continue providing support after the initial terms.<\/p>\n<p>&nbsp;<\/p>\n<div style=\"text-align: center;\">\n<p><a style=\"display: inline-block; padding: 10px 20px; background-color: #ffd300; color: #000; font-weight: bold; text-decoration: none; border-radius: 4px; box-shadow: 0px 3px 5px rgba(0, 0, 0, 0.2); transition: background-color 0.3s ease;\" href=\"https:\/\/www.oxfordcorp.com\/contact\/?utm_source=Insights&amp;utm_medium=CTA_Click&amp;utm_campaign=CTA#i'm-looking-for-talent\">CONNECT WITH OXFORD \u2192<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Explore how a leading manufacturer of genomic profiling tests addresses FDA and ISO audit observations related to CAPA management with Oxford&#8217;s support.<\/p>\n","protected":false},"author":9,"featured_media":57827,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[181],"tags":[113],"category-tag":[],"class_list":["post-57826","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-case-study","tag-life-sciences"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.1 (Yoast SEO v27.1.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>50 CAPA Remediated for Genomic Testing Manufacturer\u200b - Oxford Global Resources<\/title>\n<meta name=\"description\" content=\"Explore how a leading manufacturer of genomic profiling tests addresses FDA and ISO audit observations related to CAPA management with Oxford&#039;s support.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.oxfordcorp.com\/insights\/case-study\/50-capa-remediated-for-genomic-testing-manufacturer\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"50 CAPA Remediated for Genomic Testing Manufacturer\u200b\" \/>\n<meta property=\"og:description\" content=\"Explore how a leading manufacturer of genomic profiling tests addresses FDA and ISO audit observations related to CAPA management with Oxford&#039;s support.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.oxfordcorp.com\/insights\/case-study\/50-capa-remediated-for-genomic-testing-manufacturer\/\" \/>\n<meta property=\"og:site_name\" content=\"Oxford Global Resources\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-04T23:46:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-05T22:34:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.oxfordcorp.com\/wp-content\/uploads\/2025\/11\/GettyImages-1158724314-1-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"caitlin_charles\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"caitlin_charles\" \/>\n\t<meta name=\"twitter:label2\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.oxfordcorp.com\/insights\/case-study\/50-capa-remediated-for-genomic-testing-manufacturer\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.oxfordcorp.com\/insights\/case-study\/50-capa-remediated-for-genomic-testing-manufacturer\/\"},\"author\":{\"name\":\"caitlin_charles\",\"@id\":\"https:\/\/www.oxfordcorp.com\/de\/#\/schema\/person\/222e7aa67bdcd7a2b204fbde801f56de\"},\"headline\":\"50 CAPA Remediated for Genomic Testing Manufacturer\u200b\",\"datePublished\":\"2025-11-04T23:46:44+00:00\",\"dateModified\":\"2025-11-05T22:34:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.oxfordcorp.com\/insights\/case-study\/50-capa-remediated-for-genomic-testing-manufacturer\/\"},\"wordCount\":349,\"image\":{\"@id\":\"https:\/\/www.oxfordcorp.com\/insights\/case-study\/50-capa-remediated-for-genomic-testing-manufacturer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.oxfordcorp.com\/wp-content\/uploads\/2025\/11\/GettyImages-1158724314-1-scaled.jpg\",\"keywords\":[\"Life Sciences\"],\"articleSection\":[\"Case Study\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.oxfordcorp.com\/insights\/case-study\/50-capa-remediated-for-genomic-testing-manufacturer\/\",\"url\":\"https:\/\/www.oxfordcorp.com\/insights\/case-study\/50-capa-remediated-for-genomic-testing-manufacturer\/\",\"name\":\"50 CAPA Remediated for Genomic Testing Manufacturer\u200b - Oxford Global Resources\",\"isPartOf\":{\"@id\":\"https:\/\/www.oxfordcorp.com\/de\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.oxfordcorp.com\/insights\/case-study\/50-capa-remediated-for-genomic-testing-manufacturer\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.oxfordcorp.com\/insights\/case-study\/50-capa-remediated-for-genomic-testing-manufacturer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.oxfordcorp.com\/wp-content\/uploads\/2025\/11\/GettyImages-1158724314-1-scaled.jpg\",\"datePublished\":\"2025-11-04T23:46:44+00:00\",\"dateModified\":\"2025-11-05T22:34:16+00:00\",\"author\":{\"@id\":\"https:\/\/www.oxfordcorp.com\/de\/#\/schema\/person\/222e7aa67bdcd7a2b204fbde801f56de\"},\"description\":\"Explore how a leading manufacturer of genomic profiling tests addresses FDA and ISO audit observations related to CAPA management with Oxford's support.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.oxfordcorp.com\/insights\/case-study\/50-capa-remediated-for-genomic-testing-manufacturer\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.oxfordcorp.com\/insights\/case-study\/50-capa-remediated-for-genomic-testing-manufacturer\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/www.oxfordcorp.com\/insights\/case-study\/50-capa-remediated-for-genomic-testing-manufacturer\/#primaryimage\",\"url\":\"https:\/\/www.oxfordcorp.com\/wp-content\/uploads\/2025\/11\/GettyImages-1158724314-1-scaled.jpg\",\"contentUrl\":\"https:\/\/www.oxfordcorp.com\/wp-content\/uploads\/2025\/11\/GettyImages-1158724314-1-scaled.jpg\",\"width\":1600,\"height\":1067,\"caption\":\"Oxford provided CAPA remediation support\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.oxfordcorp.com\/insights\/case-study\/50-capa-remediated-for-genomic-testing-manufacturer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.oxfordcorp.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"50 CAPA Remediated for Genomic Testing Manufacturer\u200b\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.oxfordcorp.com\/de\/#website\",\"url\":\"https:\/\/www.oxfordcorp.com\/de\/\",\"name\":\"Oxford Global Resources\",\"description\":\"Global\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.oxfordcorp.com\/de\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.oxfordcorp.com\/de\/#\/schema\/person\/222e7aa67bdcd7a2b204fbde801f56de\",\"name\":\"caitlin_charles\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/www.oxfordcorp.com\/de\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/99261133ffbbe17417e47527427de1247c65b2702cf12681488620aa21ab8e70?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/99261133ffbbe17417e47527427de1247c65b2702cf12681488620aa21ab8e70?s=96&d=mm&r=g\",\"caption\":\"caitlin_charles\"},\"url\":\"https:\/\/www.oxfordcorp.com\/nl\/insights\/author\/caitlin_charles\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"50 CAPA Remediated for Genomic Testing Manufacturer\u200b - Oxford Global Resources","description":"Explore how a leading manufacturer of genomic profiling tests addresses FDA and ISO audit observations related to CAPA management with Oxford's support.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/50-capa-remediated-for-genomic-testing-manufacturer\/","og_locale":"nl_NL","og_type":"article","og_title":"50 CAPA Remediated for Genomic Testing Manufacturer\u200b","og_description":"Explore how a leading manufacturer of genomic profiling tests addresses FDA and ISO audit observations related to CAPA management with Oxford's support.","og_url":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/50-capa-remediated-for-genomic-testing-manufacturer\/","og_site_name":"Oxford Global Resources","article_published_time":"2025-11-04T23:46:44+00:00","article_modified_time":"2025-11-05T22:34:16+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/www.oxfordcorp.com\/wp-content\/uploads\/2025\/11\/GettyImages-1158724314-1-scaled.jpg","type":"image\/jpeg"}],"author":"caitlin_charles","twitter_card":"summary_large_image","twitter_misc":{"Geschreven door":"caitlin_charles","Geschatte leestijd":"2 minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/50-capa-remediated-for-genomic-testing-manufacturer\/#article","isPartOf":{"@id":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/50-capa-remediated-for-genomic-testing-manufacturer\/"},"author":{"name":"caitlin_charles","@id":"https:\/\/www.oxfordcorp.com\/de\/#\/schema\/person\/222e7aa67bdcd7a2b204fbde801f56de"},"headline":"50 CAPA Remediated for Genomic Testing Manufacturer\u200b","datePublished":"2025-11-04T23:46:44+00:00","dateModified":"2025-11-05T22:34:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/50-capa-remediated-for-genomic-testing-manufacturer\/"},"wordCount":349,"image":{"@id":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/50-capa-remediated-for-genomic-testing-manufacturer\/#primaryimage"},"thumbnailUrl":"https:\/\/www.oxfordcorp.com\/wp-content\/uploads\/2025\/11\/GettyImages-1158724314-1-scaled.jpg","keywords":["Life Sciences"],"articleSection":["Case Study"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/50-capa-remediated-for-genomic-testing-manufacturer\/","url":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/50-capa-remediated-for-genomic-testing-manufacturer\/","name":"50 CAPA Remediated for Genomic Testing Manufacturer\u200b - Oxford Global Resources","isPartOf":{"@id":"https:\/\/www.oxfordcorp.com\/de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/50-capa-remediated-for-genomic-testing-manufacturer\/#primaryimage"},"image":{"@id":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/50-capa-remediated-for-genomic-testing-manufacturer\/#primaryimage"},"thumbnailUrl":"https:\/\/www.oxfordcorp.com\/wp-content\/uploads\/2025\/11\/GettyImages-1158724314-1-scaled.jpg","datePublished":"2025-11-04T23:46:44+00:00","dateModified":"2025-11-05T22:34:16+00:00","author":{"@id":"https:\/\/www.oxfordcorp.com\/de\/#\/schema\/person\/222e7aa67bdcd7a2b204fbde801f56de"},"description":"Explore how a leading manufacturer of genomic profiling tests addresses FDA and ISO audit observations related to CAPA management with Oxford's support.","breadcrumb":{"@id":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/50-capa-remediated-for-genomic-testing-manufacturer\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.oxfordcorp.com\/insights\/case-study\/50-capa-remediated-for-genomic-testing-manufacturer\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/50-capa-remediated-for-genomic-testing-manufacturer\/#primaryimage","url":"https:\/\/www.oxfordcorp.com\/wp-content\/uploads\/2025\/11\/GettyImages-1158724314-1-scaled.jpg","contentUrl":"https:\/\/www.oxfordcorp.com\/wp-content\/uploads\/2025\/11\/GettyImages-1158724314-1-scaled.jpg","width":1600,"height":1067,"caption":"Oxford provided CAPA remediation support"},{"@type":"BreadcrumbList","@id":"https:\/\/www.oxfordcorp.com\/insights\/case-study\/50-capa-remediated-for-genomic-testing-manufacturer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.oxfordcorp.com\/"},{"@type":"ListItem","position":2,"name":"50 CAPA Remediated for Genomic Testing Manufacturer\u200b"}]},{"@type":"WebSite","@id":"https:\/\/www.oxfordcorp.com\/de\/#website","url":"https:\/\/www.oxfordcorp.com\/de\/","name":"Oxford Global Resources","description":"Global","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.oxfordcorp.com\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Person","@id":"https:\/\/www.oxfordcorp.com\/de\/#\/schema\/person\/222e7aa67bdcd7a2b204fbde801f56de","name":"caitlin_charles","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.oxfordcorp.com\/de\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/99261133ffbbe17417e47527427de1247c65b2702cf12681488620aa21ab8e70?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/99261133ffbbe17417e47527427de1247c65b2702cf12681488620aa21ab8e70?s=96&d=mm&r=g","caption":"caitlin_charles"},"url":"https:\/\/www.oxfordcorp.com\/nl\/insights\/author\/caitlin_charles\/"}]}},"_links":{"self":[{"href":"https:\/\/www.oxfordcorp.com\/nl\/wp-json\/wp\/v2\/posts\/57826","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.oxfordcorp.com\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.oxfordcorp.com\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.oxfordcorp.com\/nl\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.oxfordcorp.com\/nl\/wp-json\/wp\/v2\/comments?post=57826"}],"version-history":[{"count":0,"href":"https:\/\/www.oxfordcorp.com\/nl\/wp-json\/wp\/v2\/posts\/57826\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.oxfordcorp.com\/nl\/wp-json\/wp\/v2\/media\/57827"}],"wp:attachment":[{"href":"https:\/\/www.oxfordcorp.com\/nl\/wp-json\/wp\/v2\/media?parent=57826"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.oxfordcorp.com\/nl\/wp-json\/wp\/v2\/categories?post=57826"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.oxfordcorp.com\/nl\/wp-json\/wp\/v2\/tags?post=57826"},{"taxonomy":"category-tag","embeddable":true,"href":"https:\/\/www.oxfordcorp.com\/nl\/wp-json\/wp\/v2\/category-tag?post=57826"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}